Labshake search
Citations for Tocris :
551 - 600 of 1235 citations for 6 aminonaphthalene 1 3 disulphonic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... and substracted from background noise by detecting events in the last 4 seconds of 5 EPSCs at 0.2 Hz in 3 mM NBQX (Tocris) in extracellular solution.
-
bioRxiv - Developmental Biology 2020Quote: ... day 3 NMP-like cell cultures were treated with Accutase and replated at a density of 63,000 cells//cm2 in N2B27 supplemented with CHIR99021 (3 µM, Tocris), FGF2 (100 ng/ml ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... N,N’-Dicyclohexylcarbamimidothioic acid (5,6-dihydro-6,6-dimethylimidazo[2,1-b]thiazol-3-yl)methyl ester dihydrochloride (IT1t) was purchased from Tocris (United Kingdom). Bovine serum albumin ...
-
bioRxiv - Neuroscience 2023Quote: Pharmacological inhibition of AQP4 was achieved using TGN-020 (N-1,3,4-thiadiazol-2-yl-3-pyridinecarboxamide, Tocris Bioscience, UK). Unless otherwise stated ...
-
Sexual dimorphism of insular cortex function in persistent alcohol drinking despite aversion in micebioRxiv - Neuroscience 2023Quote: ... The causal role of aIC or pIC glutamatergic neurons on drinking was tested after injection of CNO (i.p. 3 mg/kg in NaCl, Tocris) or vehicle 30 minutes before the last session of binge (day 18) ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Torin1 (1 μM, Tocris, 10-1-4247), and AICAR (2 mM ...
-
bioRxiv - Developmental Biology 2022Quote: ... and endothelin 1 (ET-1) from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2019Quote: ... N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide (ANA12, 10 µM) (Tocris), (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester (K252a ...
-
bioRxiv - Neuroscience 2020Quote: ... placed in an aCSF-filled borosilicate glass pipette (3-5 MΩ) in the presence of 6,7-Dinitroquinoxaline-2,3-dione (DNQX; 10 μM; Tocris #14A/166549).
-
bioRxiv - Neuroscience 2020Quote: ... 4-Butoxy-N-[1,4-dihydro-2-(4-methoxyphenyl)-4-oxo-3(2H)-quinazolinyl]benzamide) and antagonist WRW4 (Trp-Arg-Trp-Trp-Trp-Trp-NH2) were purchased from Tocris Ltd ...
-
bioRxiv - Neuroscience 2022Quote: ... animals were treated with the selective positive allosteric modulator (PAM) of mGluR5 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB; Tocris, UK) that was diluted in saline solution containing 5-10% final concentration of DMSO and polyethylene glycol 400 (DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... The mGluR5 specific negative allosteric modulator MTEP (3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine hydrochloride) was purchased from Tocris (2921) and administered to brain slices at 1 μM by bath perfusion ...
-
bioRxiv - Neuroscience 2021Quote: ... Hox propagation was initiated by activation of Wnt signaling using NMP media comprised of E6 medium supplemented with 200 ng/mL FGF8b and 3 μM CHIR99021 (Tocris). This constitutes the “Hox timepoint” of 0hrs ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 0.3 or 1 mg/kg of the mGlu2/3 receptor agonist LY379268 (Cat No.: 2453, Batch No.: 9B/232416, CAS No.: 191471-52-0, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2022Quote: ... 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolol[1,5-a]pyrimidin-3-yl]phenol (PHTPP, 10 μM dissolved in 10% DMSO, TOCRIS, Minneapolis, MN), microinjected bilaterally into the CeA (0.5 μL over one minute with a one-minute wait post-infusion ...
-
bioRxiv - Cell Biology 2023Quote: iPSCs were first differentiated into iAT2s and passaged as above in 3D cultures in iAT2 medium (CK+DCI) supplemented for the first 3 days after passaging with 10 uM Y-27632 (Tocris). To generate iAT1s ...
-
bioRxiv - Neuroscience 2023Quote: ... Extracellular action potentials were recorded in 3 independent cultures for either genotype in the presence of 50nM nifedipine (Tocris Bioscience) or vehicle using the MaestroPro (Axion Biosystems ...
-
bioRxiv - Bioengineering 2023Quote: ... The media were changed at day 3 to remove the ROCK inhibitor and to add 10 µM DAPT (Tocris Bioscience), which remained until day 7 ...
-
bioRxiv - Genomics 2021Quote: ... and 1 μM tetrodotoxin (TTX; Tocris #1078/1). KCl (55mM ...
-
bioRxiv - Cell Biology 2020Quote: ... and diabetic NOD mice (14-26 weeks; n=3) were intra-peritoneally injected with 50mg/kg of Chloroquine diphosphate (Tocris #4109). Two hours post injection ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... supplemented with 100 ng/mL Activin A (R&D, Minneapolis, MN, USA) and 3–5 µM CHIR99021 (Tocris Bioscience, Bristol, UK) (differentiation day 0 ...
-
bioRxiv - Neuroscience 2022Quote: ... 12-well plates at 3-4 × 105 cells/well in mTeSR1 with 10 µM rho-kinase inhibitor (Y-27632; Tocris, 1254). Medium without the inhibitor was replaced daily until the cells reach 80-100% confluency ...
-
bioRxiv - Systems Biology 2020Quote: ... On Day 3 we changed the medium to RPMI + 2% B-27 (minus insulin) + 1uM Xav 939 (Tocris Bioscience, cat. 3748) and incubated the cells for 48 hours ...
-
bioRxiv - Cell Biology 2020Quote: ... into fibronectin-coated wells of two 96 well plates per biological replicate to assess proliferation on day 0 (D0) and day 3 (D3) in the presence or absence of 10 μM RARβ antagonist LE135 (Tocris Bioscience) using the cell viability MTS assay ...
-
bioRxiv - Neuroscience 2023Quote: ... 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl) hydrazino]carbonyl]benzyl]benzene-sulfonamide (TCN 201, 3 μM dissolved in DMSO; Tocris Bioscience), (αR,βS)-α-(4-Hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (Ro25-6981 ...
-
bioRxiv - Biochemistry 2022Quote: ... Positive clones were analyzed by Sanger sequencing with primers #3 and #4 (Integrated DNA Technologies, Supplementary Table S5) and degradation upon dTAG-13 (Tocris, 6605) treatment was confirmed by Western Blot by a-Chaf1a antibody (65) ...
-
bioRxiv - Physiology 2023Quote: ... PAH was induced by a single subcutaneous injection of SU5416 (SU:3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydroindol-2-one) (Tocris, Bristol, United Kingdom) in 0.5% carboxymethyl cellulose followed by 3-weeks chronic hypoxia (9-10% O2) ...
-
bioRxiv - Cell Biology 2022Quote: ... MLSA1 (Tocris, 4746, incubation 1 μM for 1 h). For all experiments in microfluidic chips involving drugs ...
-
bioRxiv - Neuroscience 2020Quote: ... rabbit anti-GLT-1 (Tocris, #2063, dilution 1:2000). Secondary antibodies against mouse ...
-
bioRxiv - Neuroscience 2021Quote: ... n=20) group were randomized to receive either saline or GLP-1R antagonist Exendin-3(9-39)amide (Ex-9) (Tocris Bioscience, UK) (85 μg/kg dissolved in saline ...
-
bioRxiv - Genomics 2022Quote: ... iPS cells were grown to 80– 90% confluence and changed into CM Media supplemented with 3 μM CHIR99021 (Tocris Biosciences, Bristol, UK) for 2 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... Proteins were then transferred onto PVDF membranes (Cytiva, Catalog #: 10600023) using a wet transfer approach and membranes were then blocked with 3% bovine serum albumin (Tocris, Catalog #: 5217) and probed for CDC42 (Cell Signaling Technology ...
-
bioRxiv - Biophysics 2022Quote: ... 50 μL well-1 of 2X neurotensin 1-13 (Tocris) solutions were added to the appropriate well and incubated for an additional 30 min ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 DAMGO (Tocris), 10 Bombesin (Tocris) ...
-
bioRxiv - Cell Biology 2019Quote: ... ITD-1 (Tocris) compound was administrated at 5mM.
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Neuroscience 2019Quote: ... and 1% P/S) supplemented with 1 µM purmorphamine (Tocris Bioscience), a SHH agonist ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cell Biology 2021Quote: ... and 6-O-[(4,5-Dimethoxy-2-nitrophenyl)methyl]-2,3-O-(1-methylethylidene)-D-myo-Inositol 1,4,5-tris[bis[(1-oxopropoxy)methyl]phosphate] (ci-IP3/PM; 1 μM, Tocris #6210) in imaging buffer with 0.01 % BSA in dark at room temperature ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Immunology 2019Quote: ... 1 uM capsaicin (Tocris) and 40 mM KCl (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... dAP5 (1 mM, Tocris) was topically applied to the dura mater ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 μM dexamethasone (Tocris) and 10 nM LONG R3 IGF-1 (IGF ...
-
bioRxiv - Neuroscience 2020Quote: ... MPEP (1 μM, Tocris), NBQX (10 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... 1 μM oxytocin (Tocris) in ACSF was washed on for 10-15 minutes ...
-
bioRxiv - Neuroscience 2020Quote: ... MRS2500 (1 µM, Tocris) was applied by addition to superfused ACSF.
-
bioRxiv - Developmental Biology 2022Quote: ... FIIN-1 (20nM, Tocris), Fgfr2iiib-Fc (1µg/ml ...